Omega-3 fatty acids in the maintenance of ulcerative colitis

Cinzia Papadia, Alessandro Coruzzi, Chiara Montana, Francesco Di Mario, Angelo Franzè, Alastair Forbes

Research output: Contribution to journalArticlepeer-review


Immunomodulation of the gut associated lynphoid tissue is a key issue in the clinical management of inflammatory bowel disease (IBD). Often toxic drugs are used to obtain clinical remission, sometimes in already immunocompromized patients. The presence of important co-morbidity might also heavily affect the clinical strategy. Polyunsaturated fatty acids (PUFAs) might represent a valid therapeutical option in IBD patients and further controlled clinical studies are warranted.
Original languageEnglish
Article number15
JournalJRSM Open
Issue number1
Publication statusPublished - 1 Jun 2010

Cite this